XBIT
XBiotech Inc
NASDAQ: XBIT · HEALTHCARE · BIOTECHNOLOGY
$2.57
+1.98% today
Updated 2026-04-30
Market cap
$77.44M
P/E ratio
—
P/S ratio
12.23x
EPS (TTM)
$-1.49
Dividend yield
—
52W range
$2 – $4
Volume
0.0M
XBiotech Inc (XBIT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-28.20%
ROA
-19.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-15.16M | — | — | — |
| 2013 | — | $-9.93M | — | — | — |
| 2014 | $0.00 | $-21.72M | — | — | — |
| 2015 | $0.00 | $-37.48M | — | — | — |
| 2016 | $0.00 | $-52.76M | — | — | — |
| 2017 | $0.00 | $-33.15M | — | — | — |
| 2018 | $0.00 | $-21.14M | — | — | — |
| 2019 | $12.68M | $668.63M | -18.62% | -246.30% | 5,272.68% |
| 2020 | $44.00M | $-11.22M | 21.48% | -41.54% | -25.50% |
| 2021 | $18.39M | $-17.41M | 68.36% | -136.36% | -94.67% |
| 2022 | $4.01M | $-32.90M | 83.77% | -860.10% | -820.45% |
| 2023 | $300000.00 | $-24.56M | -581.33% | -12,503.33% | -8,185.67% |
| 2024 | $0.00 | $-38.53M | — | — | — |
| 2025 | $0.00 | $-45.54M | — | — | — |